keidkeidHome
8-KFiling Date: Jul 6, 2026

Regeneron (REGN) 8-K: Earnings Release (Jul 6, 2026)

REGENERON PHARMACEUTICALS, INC.

View SEC Filing
ACC: 0001104659-26-080562

Event Type

Earnings Release

Filing overview

Regeneron (REGN) filed a Form 8-K (Material Event (8-K)) with the SEC on 2026-07-06. Reported items: Item 2.02 Earnings Release.

More filings from Regeneron (REGN)

  • 8-KRegeneron (REGN) 8-K · Oct 6, 2026Material Agreement; Earnings Release; Other Events
  • 8-KRegeneron (REGN) 8-K · Sep 30, 2026Executive Change; Financial Statements
  • 10-QRegeneron (REGN) 10-Q · Jul 30, 2026Quarterly Report · ended 2026-06-30 · Rev $4.3B, NI $1.3B
  • 8-KRegeneron (REGN) 8-K · Jul 30, 2026Earnings Release; Financial Statements
  • 8-KRegeneron (REGN) 8-K · Jun 17, 2026
  • 10-QRegeneron (REGN) 10-Q · Apr 29, 2026

Recent 8-K filings from other companies

  • 8-KStryker (SYK) 8-K · Oct 6, 2026Executive Change; Reg FD Disclosure; Financial Statements
  • 8-KMckesson 8-K · Oct 6, 2026Reg FD Disclosure; Financial Statements
  • 8-KB&G Foods (BGS) 8-K · Oct 6, 2026Reg FD Disclosure; Other Events; Financial Statements
  • 8-KDigital Realty Trust (DLR) 8-K · Oct 6, 2026Other Events
  • 8-KAmc Entertainment 8-K · Oct 6, 2026Material Agreement; Agreement Termination; Financial Obligation; Reg…
R

Regeneron (REGN)

8-KREGN

Material Event (8-K)

Filing Date
Jul 6, 2026
Document
REGENERON PHARMACEUTICALS, INC.
ACC
0001104659-26-080562
View SEC Filing

keid analysis is for reference only and does not constitute investment advice.